490 related articles for article (PubMed ID: 28095797)
1. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
[TBL] [Abstract][Full Text] [Related]
4. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
[TBL] [Abstract][Full Text] [Related]
5. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.
Brunet L; Moodie EEM; Young J; Cox J; Hull M; Cooper C; Walmsley S; Martel-Laferrière V; Rachlis A; Klein MB; ; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haider S; Sadr A; Johnston L; Hull M; Montaner J; Moodie E; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall JM; Vachon ML; Sanche S; Skinner S; Wong D
Clin Infect Dis; 2016 Jan; 62(2):242-249. PubMed ID: 26400998
[TBL] [Abstract][Full Text] [Related]
6. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB;
HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567
[TBL] [Abstract][Full Text] [Related]
7. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
[TBL] [Abstract][Full Text] [Related]
8. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
[TBL] [Abstract][Full Text] [Related]
9. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection.
Moqueet N; Cooper C; Gill J; Hull M; Platt RW; Klein MB;
J Infect Dis; 2016 Jul; 214(1):80-6. PubMed ID: 26984148
[TBL] [Abstract][Full Text] [Related]
10. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
Derbala M; Elbadri ME; Amer AM; AlKaabi S; Sultan KH; Kamel YM; Elsayed EH; Avades TY; Chandra P; Shebl FM
World J Gastroenterol; 2015 Dec; 21(46):13132-9. PubMed ID: 26674154
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
12. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
[TBL] [Abstract][Full Text] [Related]
13. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A
J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339
[TBL] [Abstract][Full Text] [Related]
14. Causative factors of liver fibrosis in HIV-infected patients. A single center study.
Androutsakos T; Schina M; Pouliakis A; Kontos A; Sipsas N; Hatzis G
BMC Gastroenterol; 2020 Apr; 20(1):91. PubMed ID: 32252653
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
[TBL] [Abstract][Full Text] [Related]
16. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
Bambha K; Pierce C; Cox C; French AL; Tien PC; Sharp GB; Augenbraun M; Glesby MJ; Villacres MC; Plankey M; Strickler HD; Gange SJ; Peters MG
AIDS; 2012 Mar; 26(5):599-607. PubMed ID: 22156972
[TBL] [Abstract][Full Text] [Related]
17. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.
Fuster D; Tsui JI; Cheng DM; Quinn EK; Bridden C; Nunes D; Libman H; Saitz R; Samet JH
Alcohol Clin Exp Res; 2013 Sep; 37(9):1527-35. PubMed ID: 23647488
[TBL] [Abstract][Full Text] [Related]
18. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
Al-Mohri H; Murphy T; Lu Y; Lalonde RG; Klein MB
J Acquir Immune Defic Syndr; 2007 Apr; 44(4):463-9. PubMed ID: 17211282
[TBL] [Abstract][Full Text] [Related]
19. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
20. Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.
Chen JY; Ren Y; Yan P; Belina ME; Chung RT; Butt AA
J Viral Hepat; 2018 Jul; 25(7):825-833. PubMed ID: 29478294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
